SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Idorsia Enrolls First Patients in QUVIVIQ Trial for US Label Update

Idorsia says it has enrolled the first patients in a QUVIVIQ trial seeking a US label update for daytime functioning benefits.

Related stories